Anteros Pharmaceuticals

Bristol-Myers forms fibrotic disease biotech, bags buyout option
Fierce Biotech
Tue, 02/4/20 - 10:08 am
Bristol-Myers Squibb
BioMotiv
Anteros Pharmaceuticals
fibrotic disease